Correlation Between AbbVie and Evaxion Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AbbVie and Evaxion Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AbbVie and Evaxion Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AbbVie Inc and Evaxion Biotech AS, you can compare the effects of market volatilities on AbbVie and Evaxion Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AbbVie with a short position of Evaxion Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of AbbVie and Evaxion Biotech.

Diversification Opportunities for AbbVie and Evaxion Biotech

0.8
  Correlation Coefficient

Very poor diversification

The 3 months correlation between AbbVie and Evaxion is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding AbbVie Inc and Evaxion Biotech AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evaxion Biotech AS and AbbVie is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AbbVie Inc are associated (or correlated) with Evaxion Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evaxion Biotech AS has no effect on the direction of AbbVie i.e., AbbVie and Evaxion Biotech go up and down completely randomly.

Pair Corralation between AbbVie and Evaxion Biotech

Given the investment horizon of 90 days AbbVie Inc is expected to generate 0.15 times more return on investment than Evaxion Biotech. However, AbbVie Inc is 6.75 times less risky than Evaxion Biotech. It trades about 0.07 of its potential returns per unit of risk. Evaxion Biotech AS is currently generating about -0.03 per unit of risk. If you would invest  13,342  in AbbVie Inc on September 14, 2024 and sell it today you would earn a total of  3,992  from holding AbbVie Inc or generate 29.92% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

AbbVie Inc  vs.  Evaxion Biotech AS

 Performance 
       Timeline  
AbbVie Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AbbVie Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's fundamental drivers remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Evaxion Biotech AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Evaxion Biotech AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

AbbVie and Evaxion Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AbbVie and Evaxion Biotech

The main advantage of trading using opposite AbbVie and Evaxion Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AbbVie position performs unexpectedly, Evaxion Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evaxion Biotech will offset losses from the drop in Evaxion Biotech's long position.
The idea behind AbbVie Inc and Evaxion Biotech AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes